Skip to main content
Caplight Logo









Eldec Pharmaceuticals

Eldec Pharmaceuticals

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://eldecpharmaceuticals.com/

Last Round

Grant

Apr 21, 2026

Total Funding Raised

$6.26M

Company Overview

Eldec Pharmaceuticals is a biotechnology company that develops peptide-based therapies to treat chronic lung diseases and inflammation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverypeptide therapeuticschronic lung diseasepeptidomimeticsbiotech startupOrai1 modulatorlung inflammationfibrosis treatmentpreclinical researchdrug developmenttherapeutic pipelineCOPD treatmentcystic fibrosispharma licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eldec Pharmaceuticals Comparables

Compare Eldec Pharmaceuticals with similar companies based on industry and business-model similarity.

Eldec Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biolytx Pharmaceuticals Corp.
82%
Aspiro Therapeutics
81%
Animate Biosciences
80%

Eldec Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 21, 2026
SeedFeb 9, 2024
GrantSep 1, 2023
AcceleratorMay 1, 2018

Key People

Founding team and executive leadership

Robert Schotzinger

Chairman and Acting CEO

Executive Team

Rob Hughes

CFO

Executive Team

Eldec Pharmaceuticals Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2018

    Completed an Accelerator round of funding.

Eldec Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Eldec Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eldec Pharmaceuticals's valuation, stock price, and market status.

Is Eldec Pharmaceuticals a public or private company?

Eldec Pharmaceuticals is a private company.

What is the current stock price of Eldec Pharmaceuticals?

Eldec Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Eldec Pharmaceuticals worth (valuation)?

Valuation information for Eldec Pharmaceuticals is not publicly available.

Can I buy Eldec Pharmaceuticals stock?

Eldec Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Eldec Pharmaceuticals's last funding round?

Eldec Pharmaceuticals's most recent funding round was Grant on April 21, 2026.

Who are the main investors in Eldec Pharmaceuticals?

Key investors in Eldec Pharmaceuticals include NIH RADx, North Carolina Biotechnology Center, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences.

Will Eldec Pharmaceuticals IPO soon?

No public IPO plans have been announced for Eldec Pharmaceuticals.

How can I track Eldec Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eldec Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range3
Year Founded2017
Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?